QPTFF
Price:
$0.0133
Market Cap:
$3.11M
Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, an anti-CA-125 antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications; skin penetrating active molecules for cosmetic and pharmaceutical use; and comb...[Read more]
Industry
Biotechnology
IPO Date
2018-08-24
Stock Exchange
PNK
Ticker
QPTFF
According to Quest PharmaTech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.33. This represents a change of -123.45% compared to the average of 5.67 of the last 4 quarters.
The mean historical PE Ratio of Quest PharmaTech Inc. over the last ten years is -0.87. The current -1.33 PE Ratio has changed 15.22% with respect to the historical average. Over the past ten years (40 quarters), QPTFF's PE Ratio was at its highest in in the October 2024 quarter at 22.56. The PE Ratio was at its lowest in in the April 2023 quarter at -21.46.
Average
-0.87
Median
-0.26
Minimum
-2.97
Maximum
0.18
Discovering the peaks and valleys of Quest PharmaTech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 326.61%
Maximum Annual PE Ratio = 0.18
Minimum Annual Increase = -184.66%
Minimum Annual PE Ratio = -2.97
Year | PE Ratio | Change |
---|---|---|
2024 | -1.13 | 326.61% |
2023 | -0.26 | 74.75% |
2022 | -0.15 | -184.66% |
2021 | 0.18 | -106.01% |
The current PE Ratio of Quest PharmaTech Inc. (QPTFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.52
5-year avg
-0.87
10-year avg
-0.87
Quest PharmaTech Inc.’s PE Ratio is less than Coya Therapeutics, Inc. (-0.01), less than Cue Biopharma, Inc. (-1.29), greater than Lantern Pharma Inc. (-1.82), greater than Fennec Pharmaceuticals Inc. (-15.62), less than Eliem Therapeutics, Inc. (-1.05), greater than aTyr Pharma, Inc. (-2.03), greater than Trevi Therapeutics, Inc. (-14.98), less than AN2 Therapeutics, Inc. (-0.79), less than BioAtla, Inc. (-0.38), less than Better Therapeutics, Inc. (-0.00), greater than BiomX Inc. (-3.07), less than Fresh Tracks Therapeutics, Inc. (6.38), less than Cyclacel Pharmaceuticals, Inc. (-0.47), greater than Cingulate Inc. (-1.83), greater than Assembly Biosciences, Inc. (-2.55), greater than Instil Bio, Inc. (-2.06), less than Neoleukin Therapeutics, Inc. (-0.67), less than Spero Therapeutics, Inc. (-0.69), less than CytomX Therapeutics, Inc. (4.46), greater than BioCryst Pharmaceuticals, Inc. (-40.59), less than Kezar Life Sciences, Inc. (-0.37), less than Immunic, Inc. (-0.97), greater than Atara Biotherapeutics, Inc. (-4.89), greater than Pieris Pharmaceuticals, Inc. (-7.23),
Company | PE Ratio | Market cap |
---|---|---|
-0.01 | $95.50M | |
-1.29 | $53.28M | |
-1.82 | $36.13M | |
-15.62 | $220.12M | |
-1.05 | $342.68M | |
-2.03 | $131.12M | |
-14.98 | $613.52M | |
-0.79 | $35.91M | |
-0.38 | $23.77M | |
-0.00 | $5.45K | |
-3.07 | $13.85M | |
6.38 | $5.59M | |
-0.47 | $32.52M | |
-1.83 | $14.99M | |
-2.55 | $103.57M | |
-2.06 | $161.44M | |
-0.67 | $8.20M | |
-0.69 | $39.03M | |
4.46 | $335.57M | |
-40.59 | $2.17B | |
-0.37 | $29.22M | |
-0.97 | $88.22M | |
-4.89 | $48.32M | |
-7.23 | $17.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quest PharmaTech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Quest PharmaTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Quest PharmaTech Inc.'s PE Ratio?
How is the PE Ratio calculated for Quest PharmaTech Inc. (QPTFF)?
What is the highest PE Ratio for Quest PharmaTech Inc. (QPTFF)?
What is the 3-year average PE Ratio for Quest PharmaTech Inc. (QPTFF)?
What is the 5-year average PE Ratio for Quest PharmaTech Inc. (QPTFF)?
How does the current PE Ratio for Quest PharmaTech Inc. (QPTFF) compare to its historical average?